Experience

l'ESTBB

• France
• Higher Education
• 1 - 100 Employee

• Assistant Professor and Study Coordinator

  • Aug 2021 - Present



Lycée Léonard de Vinci Villefontaine

• France
• Higher Education
• 1 - 100 Employee

• Teacher in Life and Earth Sciences

  • Jan 2021 - Jun 2021



Lycée La Martinière Duchère

• France
• Higher Education
• 1 - 100 Employee

• Teacher in microbiology

  • Sep 2020 - Jan 2021



École normale supérieure de Lyon

• France
• Research Services
• 700 & Above Employee

• Project Manager

  • Dec 2016 - Jun 2018

  Centre International de Recherche en Infectiologie. - Virus-Like Particle Engineering. - Development of a Cas-9 protein transfer method into immune cells - Study of Crimean Congo Hemmorragic Fiever Virus entry Centre International de Recherche en Infectiologie. - Virus-Like Particle Engineering. - Development of a Cas-9 protein transfer method into immune cells - Study of Crimean Congo Hemmorragic Fiever Virus entry



EZUS LYON

• France
• Research
• 1 - 100 Employee

• Project Manager

  • Jan 2016 - Nov 2016

  Collaborative project with Lentigen technology Inc (Miltenyi) Genetic modification and targeting of B cells and CD34 cells for coagulation factors and antibody secretion. Collaborative project with Lentigen technology Inc (Miltenyi) Genetic modification and targeting of B cells and CD34 cells for coagulation factors and antibody secretion.



INSERM

• France
• Research Services
• 700 & Above Employee

• Post Doc Scientist

  • Apr 2012 - Sep 2015

  Development and evaluation of new lentiviral vectors for gene therapy - LVS pseudotyped with Measles Virus (MV-LVs) to transduce CD34+ cells - Gene transfer into B-cells to treat hemophilia - Gene transfer into immune cells to treat arthritis Development and evaluation of new lentiviral vectors for gene therapy - LVS pseudotyped with Measles Virus (MV-LVs) to transduce CD34+ cells - Gene transfer into B-cells to treat hemophilia - Gene transfer into immune cells to treat arthritis



Human Virology Department

• Lyon

• PhD student

  • Sep 2008 - Mar 2012

  New retroviral pseudotypes based on paramyxovirus envelope glycoproteins: biotherapeutic applications in gene therapy and vaccination - Transduction of healthy and malignant primary B cells by MV-LVs - Engineering of MV-LVs escaping MV neutralizing antibodies for in vivo use - Development virus like particle based vaccine against human metapneumovirus New retroviral pseudotypes based on paramyxovirus envelope glycoproteins: biotherapeutic applications in gene therapy and vaccination - Transduction of healthy and malignant primary B cells by MV-LVs - Engineering of MV-LVs escaping MV neutralizing antibodies for in vivo use - Development virus like particle based vaccine against human metapneumovirus